|
|
Substance Name: Doxycycline [USAN:INN:BAN]
RN: 564-25-0
UNII: 334895S862
InChIKey: JBIWCJUYHHGXTC-AKNGSSGZSA-N
Note
- A synthetic tetracycline derivative with similar antimicrobial activity.
Molecular Formula
- C22-H24-N2-O8
Molecular Weight
- 444.4376
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
- Antiviral (COVID-19)
- Drug / Therapeutic Agent
- Human Data
- Mutation Data
- Reproductive Effect
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Results Name
- Doxycycline [USAN:INN:BAN]
Name of Substance
- Doxycycline
- Doxycycline (anhydrous)
- Doxycycline [USAN:INN:BAN]
MeSH Heading
- Doxycycline
Synonyms
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-
- 5-Hydroxy-alpha-6-deoxytetracycline
- 6-alpha-Deoxy-5-oxytetracycline
- 6-Deoxyoxytetracycline
- 6-Deoxytetracycline
- 6alpha-Deoxy-5-oxytetracycline
- alpha-6-Deoxy-5-hydroxytetracycline
- alpha-6-Deoxyoxytetracycline
- alpha-Doxycycline
- Azudoxat
- BMY 28689
- BMY-28689
- BMY28689
- BU 3839T
- BU-3839T
- Deoxymykoin
- Dossiciclina
- Dossiciclina [DCIT]
- Doxiciclina
- Doxiciclina [INN-Spanish]
- Doxiciclina [Italian]
- Doxirobe
- Doxitard
- Doxivetin
- Doxy-Caps
- Doxy-Puren
- Doxy-Tabs
- Doxycen
- Doxychel
- Doxycycline
- Doxycyclinum
- Doxycyclinum [INN-Latin]
- Doxysol
- Doxytetracycline
- EINECS 209-271-1
- HSDB 3071
- Investin
- Liviatin
- Monodox
- Nordox
- Oracea
- Oxytetracycline, 6-deoxy-
- Ronaxan
- Spanor
- UNII-334895S862
- Vibra-tabs
- Vibramycin
- Vibramycine
- Vibravenos
- Zenavod
Systematic Names
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)-
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))-
- 2-Naphthacenecarboxamide, 4-alpha-S-(dimethylamino)-1,4,4a-alpha-5,5a-alpha,6,11,12a-octahydro-3,5-alpha,10,12,12a-alpha-pentahydroxy-6-alpha-methyl-1,11-dioxo-
- Doxycycline
Superlist Name
- Doxycycline (internal use)
Registry Numbers
CAS Registry Number
- 564-25-0
FDA UNII
- 334895S862
Other Registry Numbers
- 10597-92-9
- 7164-70-7
- 7264-10-0
Related Registry Numbers
- 17086-28-1 (mono-hydrate)
- 41411-66-9 (6-epimer, mono-hydrochloride)
- 69935-17-7 (mono-hydrochloride, di-hydrate)
- 94088-85-4 (calcium salt (1:2))
System Generated Number
- 0000564250
Structure Descriptors
InChI
InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1InChIKey
JBIWCJUYHHGXTC-AKNGSSGZSA-NSmiles
C[C@@H]1[C@H]2[C@H](O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | > 100mg/kg (100mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
dog | LD50 | oral | > 500mg/kg (500mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
mouse | LD50 | intraperitoneal | 410mg/kg (410mg/kg) | Giornale Italiano di Chemioterapia. Italian Journal of Chemotherapy. Vol. 17, Pg. 276, 1970. | |
mouse | LD50 | intravenous | 241mg/kg (241mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
mouse | LD50 | oral | 1870mg/kg (1870mg/kg) | Giornale Italiano di Chemioterapia. Italian Journal of Chemotherapy. Vol. 17, Pg. 276, 1970. | |
rat | LD50 | intraperitoneal | 378mg/kg (378mg/kg) | Therapie. Vol. 23, Pg. 575, 1968. | |
rat | LD50 | intravenous | 228mg/kg (228mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
rat | LD50 | oral | > 2gm/kg (2000mg/kg) | Pharmacological and Biochemical Properties of Drug Substances. Vol. 2, Pg. 305, 1979. | |
women | TDLo | oral | 68mg/kg/24D-I (68mg/kg) | Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991. | |
women | TDLo | oral | 68mg/kg/24D-I (68mg/kg) | Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991. | |
women | TDLo | oral | 68mg/kg/24D-I (68mg/kg) | MUSCULOSKELETAL: JOINTS | Postgraduate Medical Journal. Vol. 67, Pg. 313, 1991. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
log P (octanol-water) | -0.02 | (none) | EXP | |
Water Solubility | 630 | mg/L | 25 | EXP |
Vapor Pressure | 1.42E-23 | mm Hg | 25 | EST |
Henry's Law Constant | 4.66E-24 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 2.66E-10 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.